The Future of New York Life Sciences →
September 14th, 2016
Cambridge, MA-based C4 Therapeutics has named chief scientific officer Andrew Phillips its president. Phillips is taking over for former president and CEO Jason Fisherman, who has resigned to pursue other opportunities.
Ben Fidler is Xconomy's Deputy Editor, Biotechnology. You can e-mail him at firstname.lastname@example.org Follow @benthefidler
Join us on July 16 for a special two-part gathering that will take a unique and critical look at the Internet today, and where it is heading.
Sponsored · Whitepaper
Keep easily accessible, historical records to aid in root cause analysis for deviations
Implementing a reliable and auditable monitoring program for life science samples, assets & equipment
From Our Editors · Special Report
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.